The intestinal metabolism of bile acids is essential for the gut–liver axis in NAFLD pathophysiology due to its interaction with the hepatic and intestinal farnesoid nuclear X receptor (FXR) [41,42]. This evidence concerns the gene NR1H4 and metabolic dysfunction-associated steatotic liver disease.